Economy
L'Oreal's GLP-1 Warning: What Weight Loss Drugs Mean for Beauty Stocks and Consumer Macro
L'Oreal's chief executive has publicly acknowledged that GLP-1 weight loss drugs are materially reshaping consumer behaviour in the beauty and skincare category. The admission opens a macro-level conversation about structural demand shifts that traders in consumer discretionary, pharma, and related sectors cannot afford to ignore.